Diabetes Mellitus: all 11,089 studies
Page 99 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Improving Function, Quality of Life, Glycemia in Diabetics With DementiaWithdrawnNCT00792662Phase 4
- Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsCompletedNCT00791895Phase 4
- Clarksdale Diabetes and Metabolism Clinic CHEC StudyCompletedNCT00791453
- A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.CompletedNCT00790660Phase 2
- Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled StudyCompletedNCT00790530Not applicable
- Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With DiabetesStatus unknownNCT00790348
- Early Diabetes Resolution After Weight Loss SurgeryCompletedNCT00790309
- Safety and Efficacy Study of Encapsulated Human Islets Allotransplantation to Treat Type 1 DiabetesWithdrawnNCT00790257Phase 1
- An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of DiabetesCompletedNCT00789711
- Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 DiabetesTerminatedNCT00789282Not applicable
- A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndonesiaCompletedNCT00788853
- Impact of GBS on CVD in Type 2 Diabetes MellitusCompletedNCT00787670Not applicable
- Northern Manhattan Diabetes Community Outreach ProjectCompletedNCT00787475Not applicable
- Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With DiabetesCompletedNCT00786136Phase 4
- What Makes Exercise Feel More Difficult to Women With and Without Type 2 DiabetesCompletedNCT00785005
- Islet After Kidney Transplant for Type 1 DiabetesWithdrawnNCT00784966Phase 1/2
- The CArdiovasCulAr Diabetes & Ethanol (CASCADE) TrialCompletedNCT00784433Phase 3
- Insulin Glargine Combination Therapies in Type II DiabeticsCompletedNCT00783744Phase 3
- A Clinical Trial of Ginseng in DiabetesCompletedNCT00781534Early Phase 1
- Determinants of Insulin-induced Weight Gain in Type 2 Diabetes MellitusStatus unknownNCT00781495
- Disaster Preparedness Among Families Caring for Children With DiabetesCompletedNCT00781313
- Metabolic Adaptations to Diabetes in African AmericansCompletedNCT00780195Not applicable
- Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix InsulinCompletedNCT00775736
- Hyperglycemia and Oxidative Stress in the Human Brain With DiabetesTerminatedNCT00775541Not applicable
- Project Diabetes: Prescription for Healthy LivingTerminatedNCT00775216Not applicable
- Improving Outcomes in Underserved Women With GDMCompletedNCT00774124Not applicable
- A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I DiabetesCompletedNCT00772356Not applicable
- Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCompletedNCT00772174Phase 3
- Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)CompletedNCT00771693Phase 4
- Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT00771680
- Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and HypertensionCompletedNCT00771069
- Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
- Reducing Disparities in Diabetes Risk Through Lifestyle Changes in Community SettingsCompletedNCT00770926Not applicable
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedNCT00770835Phase 4
- Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
- Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.CompletedNCT00770445Phase 4
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)CompletedNCT00770081Phase 3
- Detection of Ischemia in Asymptomatic DiabeticsCompletedNCT00769275
- Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes MellitusCompletedNCT00767260Phase 1/2
- Diabetogenicity of Cyclosporine and TacrolimusCompletedNCT00766909Phase 4
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureCompletedNCT00766857Phase 4
- Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During RamadanTerminatedNCT00766441Phase 4
- Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight LossCompletedNCT00766298Not applicable
- Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)CompletedNCT00765830Phase 3
- Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00763347Phase 2
- Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic FeetCompletedNCT00763087Not applicable
- Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00763022Phase 3
- Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TerminatedNCT00762957Phase 3
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
- Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762684Phase 3
- Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762190Phase 3
- Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762112Phase 3
- Signaling Mechanisms and Vascular Function in Diabetes MellitusCompletedNCT00761852Phase 2/3
- Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaCompletedNCT00760448Phase 1
- Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusCompletedNCT00760344Phase 2
- Genetic Variants and Phenotypic Characteristics of Patients With T2DMStatus unknownNCT00760292
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedNCT00759720Phase 3
- The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic PatientsStatus unknownNCT00758927Phase 4
- Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-StudyCompletedNCT00757276
- Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsCompletedNCT00755833
- A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight YouthCompletedNCT00755547Phase 4
- A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.CompletedNCT00754988Phase 3
- Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWithdrawnNCT00754689Phase 3
- Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCompletedNCT00754403Phase 4
- Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic NephropathyCompletedNCT00754143Phase 1
- Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 DiabetesCompletedNCT00753181Phase 3
- Inspiratory Muscle Training in Patients With Autonomic NeuropathicStatus unknownNCT00752440Phase 4
- A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENTTerminatedNCT00751842Phase 3
- How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?Status unknownNCT00749047Phase 4
- Insulin Effects on Metabolism and Cardiovascular Function in Type 2 DiabetesStatus unknownNCT00747409Phase 4
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.CompletedNCT00747383Not applicable
- Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo StudyStatus unknownNCT00746642Not applicable
- Switch From Metformin Monotherapy to a Bitherapy With Metformin and RepaglinideCompletedNCT00745433
- Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM)CompletedNCT00745342Not applicable
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.CompletedNCT00744926Phase 3
- Treat Arterial Hypertension and Diabetes in Rural AfricaCompletedNCT00744458Not applicable
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedNCT00744367Phase 3
- Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)TerminatedNCT00743756Not applicable
- A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or ThiazolidinedioneCompletedNCT00743002Phase 2
- Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General PracticeCompletedNCT00742547Not applicable
- Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations PeoplesCompletedNCT00741702Not applicable
- A 2-Month Safety Follow-Up TrialCompletedNCT00741429
- Observational Study on Safety of Self-titration of Once Daily Levemir®CompletedNCT00740519
- Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.CompletedNCT00738907
- An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 DiabetesCompletedNCT00738153
- Diabetes in the Perioperative PeriodCompletedNCT00738114
- Variation in Sulphonylurea Response in Type 2 DiabetesTerminatedNCT00738088Phase 4
- Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas TransplantationCompletedNCT00737880Phase 4
- Randomized Crossover Study of Magnesium SupplementationCompletedNCT00737815Not applicable
- Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00737776
- Beta Cell Rescue in New Onset Type 1 Diabetes With EfalizumabWithdrawnNCT00737763Phase 2
- Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With PioglitazoneCompletedNCT00737347Phase 3
- Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes MellitusStatus unknownNCT00737152Phase 2
- Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 DiabetesCompletedNCT00736515Phase 4
- Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 DiabetesCompletedNCT00735501
- Risk of Hypoglycemia in Type 2 DiabetesCompletedNCT00734669
- Myo-inositol Administration in Gestational DiabetesStatus unknownNCT00734448Not applicable
- A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.CompletedNCT00733577Phase 1
- Metabolic Adaptation to DiabetesCompletedNCT00732862Not applicable
- The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 DiabetesCompletedNCT00732602Not applicable